US Stock MarketDetailed Quotes
XCUR Exicure
- 27.6900
- +0.9500+3.55%
Close Nov 26 16:00 ET
- 26.5300
- -1.1600-4.19%
Pre 06:19 ET
60.15MMarket Cap-13707P/E (TTM)
28.4199High20.1073Low498.97KVolume26.8700Open26.7400Pre Close12.09MTurnover43.15%Turnover RatioLossP/E (Static)2.17MShares32.490052wk High38.95P/B32.02MFloat Cap1.440052wk Low--Dividend TTM1.16MShs Float576.0000Historical High--Div YieldTTM31.09%Amplitude1.4400Historical Low24.2360Avg Price1Lot Size
About Exicure Company
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Company Profile
SymbolXCUR
Company NameExicure
Listing DateJul 31, 2019
Founded2011
CEOMr. Paul Kang
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700
Websitehttp://www.exicuretx.com
Company Executives
- Name
- Position
- Salary
- Paul Kang
- Director, Chief Executive Officer and President
- 16.94K
- Andy Yoo
- Director and Chief Restructuring Officer
- --
- Jiyoung Hwang
- Director and Chief Financial Officer
- 16.97K
- Joshua Miller
- Chief Accounting Officer
- --
- Seung Ik Baik
- Director
- --
- Minhee Eom
- Independent Director
- 5.00K
- Dongho Lee
- Independent Director
- 7.22K
- Hyuk Joon Ko
- Independent Director
- 7.22K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
